Cargando…
Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells
BACKGROUND: Cancer stem cells contribute to tumor initiation, heterogeneity, and recurrence, and are critical targets in cancer therapy. Sprouty4 (Spry4) is a potent inhibitor of signal transduction pathways elicited by receptor tyrosine kinases, and has roles in regulating cell proliferation, migra...
Autores principales: | Jing, Hongyu, Liaw, Lucy, Friesel, Robert, Vary, Calvin, Hua, Shucheng, Yang, Xuehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787021/ https://www.ncbi.nlm.nih.gov/pubmed/26973433 http://dx.doi.org/10.1186/s12935-016-0292-7 |
Ejemplares similares
-
Erratum to: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells
por: Jing, Hongyu, et al.
Publicado: (2017) -
Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
por: He, Qing, et al.
Publicado: (2016) -
Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
por: He, Qing, et al.
Publicado: (2017) -
Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism
por: Hastings, Jordan, et al.
Publicado: (2017) -
Human cytomegalovirus interleukin-10 enhances matrigel invasion of MDA-MB-231 breast cancer cells
por: Valle Oseguera, Cendy A., et al.
Publicado: (2017)